Matthew I Milowsky

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 29

Top Topics

Neoadjuvant Chemotherapy

Renal Cell Carcinoma

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Nature communications

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
N Ari Wijetunga, Kathryn H Gessner, Krishna Kanchi, Jay A Moore, Zoe Fleischmann, Dexter X Jin, Garrett M Frampton, Michael Sturdivant, Michael C Repka, Shivani Sud, David L Corcoran, Matthew D Galsky, Matthew I Milowsky, Sara E Wobker, William Y Kim, Tracy L Rose, Jeffrey S Damrauer
Poor prognosis among radiation associated bladder cancer is defined by clinicogenomic features. Cancer research communications (2024)
Jeffrey L Jensen, Olivia Bobek, Irenaeus C C Chan, Brian C Miller, David W Hillman, Glenn Heller, Todd E Druley, Andrew J Armstrong, Michael J Morris, Matthew I Milowsky, Himisha Beltran, Kelly L Bolton, Catherine C Coombs
Clonal Hematopoiesis and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Given Androgen Receptor Pathway Inhibitors (Alliance A031201). Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Eric J Miller, Tracy L Rose, Benjamin L Maughan, Matthew I Milowsky, Mehmet Asim Bilen, Bradley C Carthon, Xin Gao, Suthee Rapisuwon, Qianqian Zhao, Menggang Yu, Neeraj Agarwal, Matthew D Galsky
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade. Cancer (2024)
Wolfgang Beckabir, Mi Zhou, Jin Seok Lee, Steven P Vensko, Mark G Woodcock, Hsing-Hui Wang, Sara E Wobker, Gatphan Atassi, Alec D Wilkinson, Kenneth Fowler, Leah M Flick, Jeffrey S Damrauer, Michael R Harrison, Karen P McKinnon, Tracy L Rose, Matthew I Milowsky, Jonathan S Serody, William Y Kim, Benjamin G Vincent
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer. Nature communications 15 (1) (2024)
Wolfgang Beckabir, Mi Zhou, Jin Seok Lee, Steven P Vensko, Mark G Woodcock, Hsing-Hui Wang, Sara E Wobker, Gatphan Atassi, Alec D Wilkinson, Kenneth Fowler, Leah M Flick, Jeffrey S Damrauer, Michael R Harrison, Karen P McKinnon, Tracy L Rose, Matthew I Milowsky, Jonathan S Serody, William Y Kim, Benjamin G Vincent
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer. Nature communications 15 (1) (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Wolfgang Beckabir, Mi Zhou, Jin Seok Lee, Steven P Vensko, Mark G Woodcock, Hsing-Hui Wang, Sara E Wobker, Gatphan Atassi, Alec D Wilkinson, Kenneth Fowler, Leah M Flick, Jeffrey S Damrauer, Michael R Harrison, Karen P McKinnon, Tracy L Rose, Matthew I Milowsky, Jonathan S Serody, William Y Kim, Benjamin G Vincent
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer. Nature communications 15 (1) (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Eric J Miller, Tracy L Rose, Benjamin L Maughan, Matthew I Milowsky, Mehmet Asim Bilen, Bradley C Carthon, Xin Gao, Suthee Rapisuwon, Qianqian Zhao, Menggang Yu, Neeraj Agarwal, Matthew D Galsky
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade. Cancer 130 (9) (2024)
Eric J Miller, Tracy L Rose, Benjamin L Maughan, Matthew I Milowsky, Mehmet Asim Bilen, Bradley C Carthon, Xin Gao, Suthee Rapisuwon, Qianqian Zhao, Menggang Yu, Neeraj Agarwal, Matthew D Galsky
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade. Cancer 130 (9) (2024)
Wolfgang Beckabir, Mi Zhou, Jin Seok Lee, Steven P Vensko, Mark G Woodcock, Hsing-Hui Wang, Sara E Wobker, Gatphan Atassi, Alec D Wilkinson, Kenneth Fowler, Leah M Flick, Jeffrey S Damrauer, Michael R Harrison, Karen P McKinnon, Tracy L Rose, Matthew I Milowsky, Jonathan S Serody, William Y Kim, Benjamin G Vincent
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer. Nature communications 15 (1) (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Eric J Miller, Tracy L Rose, Benjamin L Maughan, Matthew I Milowsky, Mehmet Asim Bilen, Bradley C Carthon, Xin Gao, Suthee Rapisuwon, Qianqian Zhao, Menggang Yu, Neeraj Agarwal, Matthew D Galsky
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade. Cancer 130 (9) (2024)
Peter H O'Donnell, Matthew I Milowsky, Daniel P Petrylak, Christopher J Hoimes, Thomas W Flaig, Nataliya Mar, Helen H Moon, Terence W Friedlander, Rana R McKay, Mehmet Asim Bilen, Sandy Srinivas, Earle F Burgess, Chethan Ramamurthy, Saby George, Daniel M Geynisman, Sergio Bracarda, Delphine Borchiellini, Lionnel Geoffrois, Jose Pablo Maroto Rey, Christiano Ferrario, Anne-Sophie Carret, Yao Yu, Maria Guseva, Blanca Homet Moreno, Jonathan E Rosenberg
Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Deborah B Doroshow, Peter H O'Donnell, Jean H Hoffman-Censits, Sumati V Gupta, Ulka N Vaishampayan, Elisabeth I Heath, Philip Garcia, Qianqian Zhao, Menggang Yu, Matthew I Milowsky, Matthew D Galsky
Phase II Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations. JCO precision oncology 7 (2023)
Seth P Lerner, David J McConkey, Catherine M Tangen, Joshua J Meeks, Thomas W Flaig, Xing Hua, Siamak Daneshmand, Ajjai Shivaram Alva, M Scott Lucia, Dan Theodorescu, Amir Goldkorn, Matthew I Milowsky, Woonyoung Choi, Rick Bangs, Daniel L Gustafson, Melissa Plets, Ian M Thompson
Association of Molecular Subtypes with Pathologic Response, PFS and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
W Kimryn Rathmell, R Bryan Rumble, Peter J Van Veldhuizen, Hikmat A Al-Ahmadie, Hamid Emamekhoo, Ralph J Hauke, Alexander V Louie, Matthew I Milowsky, Ana M Molina, Tracy L Rose, Shankar Siva, Nicholas G Zaorsky, Tian Zhang, Rubina Qamar, Terry M Kungel, Bryan Lewis, Eric A Singer
Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (25) (2022)
Christopher J Hoimes, Thomas W Flaig, Matthew I Milowsky, Terence W Friedlander, Mehmet Asim Bilen, Shilpa Gupta, Sandy Srinivas, Jaime R Merchan, Rana R McKay, Daniel P Petrylak, Carolyn Sasse, Blanca Homet Moreno, Yao Yu, Anne-Sophie Carret, Jonathan E Rosenberg
Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Jeffrey S Damrauer, Wolfgang Beckabir, Jeff Klomp, Mi Zhou, Elizabeth R Plimack, Matthew D Galsky, Petros Grivas, Noah M Hahn, Peter H O'Donnell, Gopakumar V Iyer, David I Quinn, Benjamin G Vincent, Diane Zipursky Quale, Sara E Wobker, Katherine A Hoadley, William Y Kim, Matthew I Milowsky
Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer. Nature communications 13 (1) (2022)
Tracy L Rose, Michael R Harrison, Allision M Deal, Sundhar Ramalingam, Young E Whang, Blaine Brower, Mary Dunn, Chelsea K Osterman, Hillary M Heiling, Marc A Bjurlin, Angela B Smith, Matthew E Nielsen, Hung-Jui Tan, Eric Wallen, Michael E Woods, Daniel J George, Tian Zhang, Anthony Drier, William Y Kim, Matthew I Milowsky
Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (28) (2021)
Vadim S Koshkin, Nicholas Henderson, Marihella James, Divya Natesan, Dory Freeman, Amanda Nizam, Christopher T Su, Ali Raza Khaki, Chelsea K Osterman, Michael J Glover, Ryan Chiang, Dimitrios Makrakis, Rafee Talukder, Emily Lemke, T Anders Olsen, Jayanshu Jain, Albert Jang, Alicia Ali, Tanya Jindal, Jonathan Chou, Terence W Friedlander, Christopher Hoimes, Arnab Basu, Yousef Zakharia, Pedro C Barata, Mehmet A Bilen, Hamid Emamekhoo, Nancy B Davis, Sumit A Shah, Matthew I Milowsky, Shilpa Gupta, Matthew T Campbell, Petros D Grivas, Guru P Sonpavde, Deepak Kilari, Ajjai S Alva
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study. Cancer (2021)
Daniel J George, Susan Halabi, Elisabeth I Heath, A Oliver Sartor, Guru P Sonpavde, Devika Das, Rhonda L Bitting, William Berry, Patrick Healy, Monika Anand, Carol Winters, Colleen Riggan, Julie Kephart, Rhonda Wilder, Kellie Shobe, Julia Rasmussen, Matthew I Milowsky, Mark T Fleming, James Bearden, Michael Goodman, Tian Zhang, Michael R Harrison, Megan McNamara, Dadong Zhang, Bonnie L LaCroix, Rick A Kittles, Brendon M Patierno, Alexander B Sibley, Steven R Patierno, Kouros Owzar, Terry Hyslop, Jennifer A Freedman, Andrew J Armstrong
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer. Cancer 127 (16) (2021)
Chelsea K Osterman, Matthew I Milowsky
Searching for the perfect combination of drug, disease, genetic alteration, and screening test to maximize FGFR inhibition in urothelial cancer. Cancer 126 (11) (2020)
Tian Zhang, Michael R Harrison, Peter H O'Donnell, Ajjai S Alva, Noah M Hahn, Leonard J Appleman, Jeremy Cetnar, John M Burke, Mark T Fleming, Matthew I Milowsky, Amir Mortazavi, Neal Shore, Guru P Sonpavde, Emmett V Schmidt, Bojena Bitman, Veerendra Munugalavadla, Raquel Izumi, Priti Patel, Janet Staats, Cliburn Chan, Kent J Weinhold, Daniel J George
A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancer. Cancer 126 (20) (2020)
Victor A McPherson, Brendan Reardon, Aravind Bhayankara, Sasinya N Scott, Mariel E Boyd, Ilana R Garcia-Grossman, Ashley M Regazzi, Asia S McCoy, Philip H Kim, Hikmat Al-Ahmadie, Irina Ostrovnaya, Andrew J Roth, Azeez Farooki, Michael F Berger, Jonathan E Rosenberg, David B Solit, Eliezer Van Allen, Matthew I Milowsky, Dean F Bajorin, Gopakumar V Iyer
A phase 2 trial of buparlisib in patients with platinum-resistant metastatic urothelial carcinoma. Cancer 126 (20) (2020)